These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 1624542

  • 1. A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents.
    Teicher BA, Holden SA, Ara G, Ha CS, Herman TS, Northey D.
    J Cancer Res Clin Oncol; 1992; 118(7):509-14. PubMed ID: 1624542
    [Abstract] [Full Text] [Related]

  • 2. Enhancement by perflusion emulsion (Oxygent) and carbogen breathing of the tumor growth delay of the FSaIIC fibrosarcoma after treatment with antitumor alkylating agents.
    Holden SA, Teicher BA, Ha C, Ara G, Herman TS.
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):895-8. PubMed ID: 1391529
    [Abstract] [Full Text] [Related]

  • 3. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
    Teicher BA, Herman TS, Tanaka J, Eder JP, Holden SA, Bubley G, Coleman CN, Frei E.
    Cancer Res; 1991 Feb 15; 51(4):1086-91. PubMed ID: 1825474
    [Abstract] [Full Text] [Related]

  • 4. Effect of a bovine hemoglobin preparation on the response of the FSaIIC fibrosarcoma to chemotherapeutic alkylating agents.
    Teicher BA, Herman TS, Hopkins RE, Menon K.
    J Cancer Res Clin Oncol; 1992 Feb 15; 118(2):123-8. PubMed ID: 1735732
    [Abstract] [Full Text] [Related]

  • 5. Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity.
    Teicher BA, Holden SA, Jacobs JL.
    Cancer Res; 1987 Jan 15; 47(2):513-8. PubMed ID: 3098413
    [Abstract] [Full Text] [Related]

  • 6. Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma.
    Teicher BA, Herman TS, Tanaka J, Dezube B, Pardee A, Frei E.
    Cancer Chemother Pharmacol; 1991 Jan 15; 28(1):45-50. PubMed ID: 1904012
    [Abstract] [Full Text] [Related]

  • 7. Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity.
    Teicher BA, Bernal SD, Holden SA, Cathcart KN.
    Cancer Chemother Pharmacol; 1988 Jan 15; 21(4):281-5. PubMed ID: 3131032
    [Abstract] [Full Text] [Related]

  • 8. Effect of various oxygenation conditions and fluosol-DA on cancer chemotherapeutic agents.
    Teicher BA, McIntosh-Lowe NL, Rose CM.
    Biomater Artif Cells Artif Organs; 1988 Jan 15; 16(1-3):533-46. PubMed ID: 2460166
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of fluosol-DA and oxygenation status on the activity of cyclophosphamide in vivo.
    Teicher BA, Herman TS, Holden SA, Cathcart KN.
    Cancer Chemother Pharmacol; 1988 Jan 15; 21(4):286-91. PubMed ID: 3131033
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intermittent use of a perfluorochemical emulsion (Fluosol-DA 20%) and carbogen breathing with fractionated irradiation.
    Moulder JE, Fish BL.
    Int J Radiat Oncol Biol Phys; 1988 Nov 15; 15(5):1193-6. PubMed ID: 3141322
    [Abstract] [Full Text] [Related]

  • 14. Effect of Fluosol-DA on the response of intracranial 9L tumors to X rays and BCNU.
    Teicher BA, Herman TS, Rose CM.
    Int J Radiat Oncol Biol Phys; 1988 Nov 15; 15(5):1187-92. PubMed ID: 3141321
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivo.
    Tanaka J, Teicher BA, Herman TS, Holden SA, Dezube B, Frei E.
    Int J Cancer; 1991 Jun 19; 48(4):631-7. PubMed ID: 2045206
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Therapeutic effect of infused Fluosol-DA/carbogen with ephedrine, flunarizine, or nitroprusside.
    Teicher BA, Holden SA, Northey D, Dewhirst MW, Herman TS.
    Int J Radiat Oncol Biol Phys; 1993 Apr 30; 26(1):103-9. PubMed ID: 8482616
    [Abstract] [Full Text] [Related]

  • 19. Influence of scheduling, dose, and volume of administration of a perfluorochemical emulsion on tumor response to radiation therapy.
    Teicher BA, Herman TS, Jones SM.
    Int J Radiat Oncol Biol Phys; 1990 Oct 30; 19(4):945-51. PubMed ID: 2211263
    [Abstract] [Full Text] [Related]

  • 20. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
    Teicher BA, Holden SA, Ara G, Dupuis NP, Goff D.
    Cancer J Sci Am; 1995 Oct 30; 1(1):43-8. PubMed ID: 9166453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.